HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Conditions

• HCC - Hepatocellular Carcinoma
• Hepatic Arterial Infusion Chemotherapy
• BCLC Stage C Hepatocellular Carcinoma
• Lenvatinib
• PD-1 Inhibitors

Interventions

• PROCEDURE: hepatic artery infusion chemotherapy
• DRUG: Lenvatinib + PD-1 monoclonal antibody

Sponsor

First Hospital of China Medical University